MedPath

Analysis of Oxidative Stress Biomarkers and Their Determinants in ART-experienced PLWH

Recruiting
Conditions
HIV Infections
Interventions
Other: blood sampling
Registration Number
NCT05760495
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The project aims to assess the level of oxidative stress biomarkers in HIV patients on effective antiretroviral treatment in correlation with other therapeutic, clinical, and viro- immunological parameters. The analysis aims to better characterize the patient on treatment through an innovative approach based on two specific tests for complementary assessment of total oxidant and anti-oxidant plasma capacity.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
543
Inclusion Criteria
  • ART-treated PLWH
  • HIV-1 RNA< 50 copies/mL
  • Stable ART therapy (at least 48 weeks)
  • Signature of informed consent for study participation
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Single armblood samplingART-experienced PLWH
Primary Outcome Measures
NameTimeMethod
Assessment of the levels of total oxidant and antioxidant plasma capacity1 year

Quantify the levels of total oxidant and antioxidant plasma capacity antioxidant

Secondary Outcome Measures
NameTimeMethod
Correlation between level of oxidative stress biomarkers and several factors1 year

Evaluation of the impact of therapeutic, viro-immunologic, clinical, and demographic factors on the level of oxidative stress biomarkers.

Trial Locations

Locations (1)

Francesca Lombardi

🇮🇹

Roma, RM, Italy

© Copyright 2025. All Rights Reserved by MedPath